Aethlon Medical, Inc. (Nasdaq: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious ...
An increased prevalence of chronic kidney disease is expected to fuel growth in the nulojix market. The rise in chronic kidney disease is a long-term condition where the kidneys gradually lose their ...
Building on clinical data from millions of individuals who received lipid-encapsulated mRNA vaccines, the FDA has issued new guidance that could facilitate a faster transition to first-in-human trials ...